
A Brief analysis of compulsory license of drug patent under public Health Crisis
Author(s) -
Changchen LI
Publication year - 2020
Publication title -
shèhuì kēxué lǐlùn yǔ shíjiàn
Language(s) - English
Resource type - Journals
eISSN - 2664-1720
pISSN - 2664-1127
DOI - 10.6914/tpss.202006_2(2).0005
Subject(s) - license , scope (computer science) , incentive , business , negotiation , public economics , international trade , economics , law , political science , market economy , computer science , programming language
In the face of the new crown epidemic, the implementation of the drug patent compulsory licensing system is one of the problems that needs to be solved urgently. At present, my country has established a relatively complete patent compulsory licensing system, but the system still presents a "zero implementation" status in my country. my country should learn from foreign experience, improve the system design of my country's pharmaceutical patent compulsory licensing by conditionally liberalizing the scope of application subjects, raising patent license fees and other measures; at the policy level, preferentially adopt negotiation methods to weaken the trade frictions caused by the implementation of patent compulsory licensing , To balance the incentive mechanism for pharmaceutical patent innovation, and actively promote the implementation of the pharmaceutical patent compulsory licensing system in my country.